VCMCVC Market Cap
Menu

Neuralink valuation, funding and investors

neuralink.com ↗LinkedIn ↗

Neuralink works in brain-computer interface technology development, based in Fremont, United States. Founded in 2016, it has about 651 employees.

Medical Supply Manufacturers Series E
VALUATION · TODAY
$13.08B +0% after Series E
Range $8.07B – $15.05B · Grade B
TODAY
+12 MO
$5.00B
$10.00B
$15.00B
$20.00B
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Series A $107M
Series B $51.0M
Series C $205M
Series D $280M
Series E $650M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY672 employees
+3%6m growth
+12%1y growth
+220%2y growth
250
500
750
Data from Jan 2021
TODAY
Predicted in 1 yr $13.08B +0% vs today
Predicted next raise $1.44B if a round comes
Winding-down probability 0%
Last round
Series E · $650M · Jun 2025
Valuation at last round
$9.60B
Headcount
672 · up
Grade
B
Founded
2016
How VCMC values companies →

Neuralink valuation today

VCMC values Neuralink at $13.1B today, with a range of $8.1B to $15.1B and a grade of B. The valuation starts from its last funding round, a Series E round in Jun 2025.

Valuation by date (136 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Neuralink: valuation by date, as the model would have shown it on each date
DateValuationRangePredicted in 1 yrPhaseHeadcountTrendGradeWinding-down probability
1 Jan 2016$5.51M$2.00M – $15.1M$6.60M (+20%)before first round–unknownD0%
1 Feb 2016$5.53M$2.01M – $15.2M$6.78M (+23%)before first round–unknownD0%
1 Mar 2016$5.55M$2.02M – $15.2M$6.95M (+25%)before first round–unknownD0%
1 Apr 2016$5.57M$2.03M – $15.3M$7.14M (+28%)before first round–unknownD0%
1 May 2016$5.59M$2.04M – $15.4M$7.33M (+31%)before first round–unknownD0%
1 Jun 2016$5.61M$2.04M – $15.4M$7.53M (+34%)before first round–unknownD0%
1 Jul 2016$5.64M$2.05M – $15.5M$7.72M (+37%)before first round–unknownD0%
1 Aug 2016$5.79M$2.11M – $15.9M$7.93M (+37%)before first round–unknownD0%
1 Sep 2016$5.94M$2.16M – $16.3M$8.15M (+37%)before first round–unknownD0%
1 Oct 2016$6.10M$2.22M – $16.8M$8.36M (+37%)before first round–unknownD0%
1 Nov 2016$6.26M$2.28M – $17.2M$8.59M (+37%)before first round–unknownD0%
1 Dec 2016$6.43M$2.34M – $17.7M$8.81M (+37%)before first round–unknownD0%
1 Jan 2017$6.60M$2.40M – $18.1M$9.05M (+37%)before first round–unknownD0%
1 Feb 2017$6.78M$2.47M – $18.6M$9.29M (+37%)before first round–unknownD0%
1 Mar 2017$6.94M$2.53M – $19.1M$9.52M (+37%)before first round–unknownD0%
1 Apr 2017$7.13M$2.60M – $19.6M$9.78M (+37%)before first round–unknownD0%
1 May 2017$7.32M$2.67M – $20.1M$10.0M (+37%)before first round–unknownD0%
1 Jun 2017$7.52M$2.74M – $20.7M$10.3M (+37%)before first round–unknownD0%
1 Jul 2017$7.72M$2.81M – $21.2M$10.6M (+37%)before first round–unknownD0%
1 Aug 2017$594M$391M – $1.6B$1.1B (+80%)after a round–unknownC0%
2 Aug 2017$595M$391M – $1.6B$1.1B (+80%)after a round–unknownC0%
1 Sep 2017$625M$391M – $1.6B$1.1B (+71%)after a round–unknownC0%
1 Oct 2017$656M$391M – $1.6B$1.1B (+63%)after a round–unknownC0%
1 Nov 2017$689M$391M – $1.6B$1.1B (+55%)after a round–unknownC0%
1 Dec 2017$723M$391M – $1.6B$1.1B (+48%)after a round–unknownC0%
1 Jan 2018$760M$391M – $1.6B$1.1B (+41%)after a round–unknownC0%
1 Feb 2018$799M$391M – $1.6B$1.1B (+34%)after a round–unknownC0%
1 Mar 2018$836M$391M – $1.6B$1.1B (+28%)after a round–unknownC0%
1 Apr 2018$879M$391M – $1.6B$1.1B (+22%)after a round–unknownC0%
1 May 2018$922M$391M – $1.6B$1.1B (+16%)after a round–unknownC0%
1 Jun 2018$970M$391M – $1.6B$1.1B (+10%)after a round–unknownC0%
1 Jul 2018$1.0B$391M – $1.6B$1.1B (+5%)after a round–unknownC0%
1 Aug 2018$1.1B$391M – $1.6B$1.1B (0%)after a round–unknownC0%
1 Sep 2018$1.1B$371M – $1.6B$1.1B (0%)after a round–unknownC0%
1 Oct 2018$1.1B$353M – $1.6B$1.1B (0%)after a round–unknownC0%
1 Nov 2018$1.1B$336M – $1.6B$1.1B (0%)after a round–unknownC0%
1 Dec 2018$1.1B$320M – $1.6B$1.1B (0%)after a round–unknownC0%
1 Jan 2019$1.1B$304M – $1.6B$1.1B (0%)after a round–unknownC0%
1 Feb 2019$1.1B$289M – $1.6B$1.1B (0%)after a round–unknownC0%
1 Mar 2019$1.1B$276M – $1.6B$1.1B (0%)after a round–unknownC0%
1 Apr 2019$1.1B$262M – $1.6B$1.1B (0%)after a round–unknownC0%
16 Apr 2019$365M$239M – $832M$546M (+50%)after a round–unknownC0%
1 May 2019$371M$239M – $832M$546M (+47%)after a round–unknownC0%
1 Jun 2019$384M$239M – $832M$546M (+42%)after a round–unknownC0%
1 Jul 2019$397M$239M – $832M$546M (+38%)after a round–unknownC0%
1 Aug 2019$411M$239M – $832M$546M (+33%)after a round–unknownC0%
1 Sep 2019$425M$239M – $832M$546M (+29%)after a round–unknownC0%
1 Oct 2019$439M$239M – $832M$546M (+24%)after a round–unknownC0%
1 Nov 2019$455M$239M – $832M$546M (+20%)after a round–unknownC0%
1 Dec 2019$470M$239M – $832M$546M (+16%)after a round–unknownC0%
1 Jan 2020$487M$239M – $832M$546M (+12%)after a round–unknownC0%
1 Feb 2020$504M$239M – $832M$546M (+8%)after a round–unknownC0%
1 Mar 2020$520M$239M – $832M$546M (+5%)after a round–unknownC0%
1 Apr 2020$538M$239M – $832M$546M (+1%)after a round–unknownC0%
1 May 2020$546M$234M – $832M$546M (0%)after a round–unknownC0%
1 Jun 2020$546M$224M – $832M$546M (0%)after a round–unknownC0%
1 Jul 2020$546M$214M – $832M$546M (0%)after a round–unknownC0%
1 Aug 2020$546M$205M – $832M$546M (0%)after a round–unknownC0%
1 Sep 2020$546M$196M – $832M$546M (0%)after a round–unknownC0%
1 Oct 2020$546M$188M – $832M$546M (0%)after a round–unknownC0%
1 Nov 2020$546M$180M – $832M$546M (0%)after a round–unknownC0%
1 Dec 2020$546M$172M – $832M$546M (0%)after a round–unknownC0%
1 Jan 2021$546M$165M – $832M$546M (0%)after a round87unknownC0%
1 Feb 2021$546M$158M – $832M$546M (0%)after a round87unknownC0%
1 Mar 2021$546M$152M – $832M$546M (0%)after a round87unknownC0%
1 Apr 2021$546M$145M – $832M$546M (0%)after a round87flatC0%
1 May 2021$546M$128M – $832M$544M (0%)after a round87flatC0%
1 Jun 2021$546M$121M – $832M$539M (-1%)after a round87flatC0%
1 Jul 2021$546M$116M – $832M$535M (-2%)after a round87flatC0%
30 Jul 2021$1.6B$1.1B – $3.0B$2.1B (+30%)after a round87flatB0%
1 Aug 2021$1.6B$1.1B – $3.0B$2.1B (+30%)after a round87flatB0%
1 Sep 2021$1.7B$1.1B – $3.0B$2.1B (+27%)after a round87flatB0%
1 Oct 2021$1.7B$1.1B – $3.0B$2.1B (+24%)after a round87flatB0%
1 Nov 2021$1.7B$1.1B – $3.0B$2.1B (+21%)after a round87flatB0%
1 Dec 2021$1.8B$1.1B – $3.0B$2.1B (+19%)after a round87flatB0%
1 Jan 2022$1.8B$1.1B – $3.0B$2.1B (+16%)after a round87flatB0%
1 Feb 2022$2.0B$1.4B – $3.6B$2.5B (+25%)after a round210growingB0%
1 Mar 2022$2.1B$1.4B – $3.6B$2.5B (+21%)after a round210growingB0%
1 Apr 2022$2.2B$1.4B – $3.6B$2.5B (+16%)after a round210growingB0%
1 May 2022$2.3B$1.4B – $3.6B$2.5B (+12%)after a round210growingB0%
1 Jun 2022$2.4B$1.4B – $3.6B$2.5B (+8%)after a round210growingB0%
1 Jul 2022$2.5B$1.4B – $3.6B$2.5B (+4%)after a round210growingB0%
1 Aug 2022$2.5B$1.4B – $3.6B$2.5B (0%)after a round210growingB0%
1 Sep 2022$2.5B$1.4B – $3.6B$2.5B (0%)after a round210growingB0%
1 Oct 2022$2.5B$1.4B – $3.6B$2.5B (0%)after a round210growingB0%
1 Nov 2022$2.5B$1.2B – $3.6B$2.5B (0%)after a round210unknownB0%
1 Dec 2022$2.5B$1.1B – $3.6B$2.5B (0%)after a round210unknownB0%
1 Jan 2023$2.5B$1.1B – $3.6B$2.5B (0%)after a round210unknownB0%
1 Feb 2023$2.5B$1.0B – $3.6B$2.5B (0%)after a round210unknownC0%
1 Mar 2023$2.5B$1.0B – $3.6B$2.5B (0%)after a round210unknownC0%
1 Apr 2023$2.5B$954M – $3.6B$2.5B (0%)after a round210unknownC0%
1 May 2023$2.5B$912M – $3.6B$2.5B (0%)after a round210unknownC0%
1 Jun 2023$2.5B$871M – $3.6B$2.5B (0%)after a round210unknownC0%
1 Jul 2023$2.5B$833M – $3.6B$2.5B (0%)after a round210unknownC0%
1 Aug 2023$2.5B$753M – $3.6B$2.5B (0%)after a round210unknownC0%
8 Aug 2023$3.3B$2.3B – $6.1B$4.3B (+30%)after a round210unknownB0%
1 Sep 2023$3.4B$2.3B – $6.1B$4.3B (+28%)after a round210unknownB0%
1 Oct 2023$3.5B$2.3B – $6.1B$4.3B (+25%)after a round210unknownB0%
1 Nov 2023$3.5B$2.3B – $6.1B$4.3B (+22%)after a round210unknownB0%
1 Dec 2023$3.6B$2.3B – $6.1B$4.3B (+20%)after a round210unknownB0%
1 Jan 2024$3.7B$2.3B – $6.1B$4.3B (+17%)after a round210unknownB0%
1 Feb 2024$3.8B$2.3B – $6.1B$4.3B (+14%)after a round210unknownB0%
1 Mar 2024$3.9B$2.3B – $6.1B$4.3B (+12%)after a round210unknownB0%
1 Apr 2024$3.9B$2.3B – $6.1B$4.3B (+10%)after a round210unknownB0%
1 May 2024$4.0B$2.3B – $6.1B$4.3B (+7%)after a round210unknownB0%
1 Jun 2024$4.1B$2.3B – $6.1B$4.3B (+5%)after a round210unknownB0%
1 Jul 2024$4.2B$2.3B – $6.1B$4.3B (+3%)after a round210unknownB0%
1 Aug 2024$4.3B$2.3B – $6.1B$4.3B (0%)after a round210unknownB0%
1 Sep 2024$4.3B$2.3B – $6.1B$4.3B (0%)after a round210unknownB0%
1 Oct 2024$4.3B$2.2B – $6.1B$4.3B (0%)after a round210unknownB0%
1 Nov 2024$4.3B$2.1B – $6.1B$4.3B (0%)after a round210unknownB0%
1 Dec 2024$4.3B$2.0B – $6.1B$4.3B (0%)after a round210unknownB0%
1 Jan 2025$4.3B$1.9B – $6.1B$4.3B (0%)after a round210unknownB0%
1 Feb 2025$4.3B$1.8B – $6.1B$4.3B (0%)after a round210unknownC0%
1 Mar 2025$4.3B$1.7B – $6.1B$4.3B (0%)after a round210unknownC0%
1 Apr 2025$4.3B$1.6B – $6.1B$4.3B (0%)after a round210unknownC0%
1 May 2025$4.3B$1.6B – $6.1B$4.3B (0%)after a round210unknownC0%
1 Jun 2025$4.3B$1.5B – $6.1B$4.3B (0%)after a round210unknownC0%
3 Jun 2025$9.6B$8.3B – $14.4B$12.5B (+30%)after a round210unknownA0%
1 Jul 2025$9.8B$8.3B – $14.4B$12.5B (+27%)after a round542unknownA0%
1 Aug 2025$10.0B$8.3B – $14.4B$12.5B (+25%)after a round551flatA0%
1 Sep 2025$10.3B$8.3B – $14.4B$12.5B (+22%)after a round551flatA0%
1 Oct 2025$10.5B$8.3B – $14.7B$12.8B (+21%)after a round598flatA0%
1 Nov 2025$10.8B$8.3B – $14.7B$12.8B (+18%)after a round598flatA0%
1 Dec 2025$11.1B$8.3B – $14.7B$12.8B (+15%)after a round598flatA0%
1 Jan 2026$11.3B$8.3B – $14.7B$12.8B (+13%)after a round598flatA0%
1 Feb 2026$11.6B$8.3B – $14.7B$12.8B (+10%)after a round598flatA0%
1 Mar 2026$11.9B$8.3B – $14.7B$12.8B (+8%)after a round598flatA0%
1 Apr 2026$12.3B$8.3B – $14.9B$13.0B (+5%)after a round651upA0%
1 May 2026$12.7B$8.3B – $15.1B$13.1B (+3%)after a round672upA0%
1 Jun 2026$13.1B$8.3B – $15.1B$13.1B (0%)after a round672upA0%
1 Jul 2026$13.1B$8.3B – $15.1B$13.1B (0%)after a round672upA0%
1 Aug 2026$13.1B$8.2B – $15.1B$13.1B (0%)after a round672upB0%
1 Sep 2026$13.1B$8.2B – $15.1B$13.1B (0%)after a round672upB0%
1 Oct 2026$13.1B$8.1B – $15.1B$13.1B (0%)after a round672upB0%
24 Oct 2026$13.1B$8.1B – $15.1B$13.1B (0%)after a round672upB0%

Key facts about Neuralink

Founded
2016
Headquarters
Fremont, United States
Employees
about 651 +20% in a year
Total raised
$1.29B
Funding rounds
5
Last round
Series E Jun 2025

Neuralink was founded in 2016 by Benjamin Rapoport, Dongjin Seo, Elon Musk, Max Hodak, Paul Merolla, Philip Sabes, Tim Hanson, Timothy J. Gardner and Vanessa Tolosa.

Neuralink funding history

Neuralink has 5 funding rounds on record, from Aug 2017 to Jun 2025, $1.29B in total. The latest disclosed valuation is $9.60B post-money (Series E, Jun 2025).

  1. Series E 2 Jun 2025

    Led by DFJ Growth; with ARK Invest, Founders Fund, G42, Human Capital, Lightspeed Venture Partners, Qatar Investment Authority, Sequoia Capital, Thrive Capital, Valor, Vy Capital, Gigafund.

    Sources: neuralink.com, neuralink.com, fiercebiotech.com and 5 more

    $650M

    $9.60B post-money

  2. Series D 7 Aug 2023

    Led by Founders Fund.

    Sources: neuralink.com, cnn.com, medtechdive.com and 5 more

    $280M

  3. Series C 29 Jul 2021

    Led by Vy Capital; with GV, DFJ Growth, Valor, Craft Ventures, Founders Fund, Gigafund. Individuals: Sam Altman.

    Sources: neuralink.com, neuralink.com, internationalfinance.com and 5 more

    $205M

  4. Series B 15 Apr 2019

    Investors not disclosed.

    Sources: carre.partners

    $51M

  5. Series A 1 Aug 2017

    Investors not disclosed.

    Sources: carre.partners

    $107M

Neuralink investors

14 investors have backed Neuralink; Founders Fund, DFJ Growth and Vy Capital led at least one round.

What Neuralink does

Neuralink works in medical supply manufacturers, with 13 recorded offerings and customers in healthcare.

Neuralink Corp. is an American neurotechnology company engaged in the development and deployment of brain-computer interfaces. The company designs and manufactures implantable devices that enable wireless communication between the brain and external systems, such as computers and robotic arms. Neuralink also operates as a research and development organization, supporting clinical trials for applications in spinal cord injury and amyotrophic lateral sclerosis. Its activities include the use of surgical robots for implantation and the maintenance of a patient registry and network of healthcare providers and research partners.

Description from Veridion's company data.

Products and services

  • Brain-Computer Interface Technology Development
  • Implantable Neuroprosthetic Device Manufacturing
  • Wireless Neural Signal Processing and Transmission
  • Flexible Electrode Thread Implantation Services
  • Surgical Robot Implantation System Development
  • Clinical Trial Participation Services
  • Neurological Data Decoding Software Development
  • Human Autonomy Restoration Solutions
  • Robotic Arm Control Interface Development
  • Transhumanist Technology Advancement
  • Patient Registry Management Services
  • Healthcare Provider Collaboration Services
  • Research Partner Collaboration Services

Markets

  • Healthcare

Technology

  • Brain-Computer Interfaces
  • Wireless Neural Signal Transmission
  • Flexible, Ultra-Thin Electrode Threads for Neural Recording
  • Surgical Robot for Precise Neural Implantation
  • Custom Low-Power Chips for Neural Signal Processing

Certifications

  • HIPAA compliant

Business model

  • Business-to-Business
  • Manufacturing
  • Enterprise

Industry codes (NAICS)

  • 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing 70% match
  • 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) 30% match

Questions about Neuralink

What is Neuralink worth?

Valuation $13.1B (range $8.1B to $15.1B), as of 24 Oct 2026. The last disclosed valuation was $9.60B (Series E, Jun 2025).

Has Neuralink raised money?

Neuralink has 5 funding rounds on record, from Aug 2017 to Jun 2025, $1.29B in total. The latest disclosed valuation is $9.60B post-money (Series E, Jun 2025).

Who has invested in Neuralink?

Founders Fund, DFJ Growth, Vy Capital, Gigafund, Valor and ARK Invest, and 8 more. Lead investors include Founders Fund, DFJ Growth and Vy Capital.

How many people work at Neuralink?

About 651, up 20% over the last year. Headcount grew from 87 in Jan 2021 to 672 in May 2026.

What does Neuralink do?

Neuralink works in medical supply manufacturers, with 13 recorded offerings and customers in healthcare. Its main offerings are brain-computer interface technology development, implantable neuroprosthetic device manufacturing and wireless neural signal processing and transmission.

When was Neuralink founded, and where is it based?

Neuralink was founded in 2016 and is based in Fremont, United States. It has about 651 employees, up 20% over the last year.

How we value companiesReport an issue